Tags

Type your tag names separated by a space and hit enter

Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients?
Eur Rev Med Pharmacol Sci. 2020 Nov; 24(21):11421-11427.ER

Abstract

OBJECTIVE

This study aimed to investigate whether pre-existing chronic obstructive pulmonary disease (COPD) was an independent predictor for adverse outcomes in coronavirus disease 2019 (COVID-19) patients.

MATERIALS AND METHODS

We searched electronic databases, including PubMed, Web of Science, EMBASE, and Chinese National Knowledge Infrastructure (CNKI) to screen for eligible articles. A quantitative meta-analysis was performed on the basis of adjusted effect estimates.

RESULTS

We observed that COPD was significantly associated with an increased risk of adverse outcomes in COVID-19 patients, which is based on 18 studies with 26,075 cases reporting adjusted effect estimates (pooled effect = 1.53, 95% confidence interval (CI): 1.29-1.8; I2 = 35.4%, random-effects model).

CONCLUSIONS

We found that pre-existing COPD was an independent risk factor for predicting the adverse outcomes in COVID-19 patients.

Authors+Show Affiliations

Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China. yhy@zzu.edu.cn.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Meta-Analysis

Language

eng

PubMed ID

33215464

Citation

Xiao, W-W, et al. "Is Chronic Obstructive Pulmonary Disease an Independent Predictor for Adverse Outcomes in Coronavirus Disease 2019 Patients?" European Review for Medical and Pharmacological Sciences, vol. 24, no. 21, 2020, pp. 11421-11427.
Xiao WW, Xu J, Shi L, et al. Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients? Eur Rev Med Pharmacol Sci. 2020;24(21):11421-11427.
Xiao, W. W., Xu, J., Shi, L., Wang, Y. D., & Yang, H. Y. (2020). Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients? European Review for Medical and Pharmacological Sciences, 24(21), 11421-11427. https://doi.org/10.26355/eurrev_202011_23635
Xiao WW, et al. Is Chronic Obstructive Pulmonary Disease an Independent Predictor for Adverse Outcomes in Coronavirus Disease 2019 Patients. Eur Rev Med Pharmacol Sci. 2020;24(21):11421-11427. PubMed PMID: 33215464.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients? AU - Xiao,W-W, AU - Xu,J, AU - Shi,L, AU - Wang,Y-D, AU - Yang,H-Y, PY - 2020/11/20/entrez PY - 2020/11/21/pubmed PY - 2020/12/2/medline SP - 11421 EP - 11427 JF - European review for medical and pharmacological sciences JO - Eur Rev Med Pharmacol Sci VL - 24 IS - 21 N2 - OBJECTIVE: This study aimed to investigate whether pre-existing chronic obstructive pulmonary disease (COPD) was an independent predictor for adverse outcomes in coronavirus disease 2019 (COVID-19) patients. MATERIALS AND METHODS: We searched electronic databases, including PubMed, Web of Science, EMBASE, and Chinese National Knowledge Infrastructure (CNKI) to screen for eligible articles. A quantitative meta-analysis was performed on the basis of adjusted effect estimates. RESULTS: We observed that COPD was significantly associated with an increased risk of adverse outcomes in COVID-19 patients, which is based on 18 studies with 26,075 cases reporting adjusted effect estimates (pooled effect = 1.53, 95% confidence interval (CI): 1.29-1.8; I2 = 35.4%, random-effects model). CONCLUSIONS: We found that pre-existing COPD was an independent risk factor for predicting the adverse outcomes in COVID-19 patients. SN - 2284-0729 UR - https://www.unboundmedicine.com/medline/citation/33215464/Is_chronic_obstructive_pulmonary_disease_an_independent_predictor_for_adverse_outcomes_in_coronavirus_disease_2019_patients L2 - https://www.europeanreview.org/article/23635 DB - PRIME DP - Unbound Medicine ER -